Medstar Harbor Hospital
Baltimore, Maryland 21225
2 studies enrolling now · 12 studies all time
What they study most
ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Breast Ductal Carcinoma In Situ, Cognitive Impairment, HER2/Neu Positive, Healthy Participants, Heart Failure, Hormone Receptor Positive Malignant Neoplasm of Breast, Lumbar Spinal Stenosis, Lung Non-Squamous Non-Small Cell Carcinoma, Palliative
Studies at this site
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study — Recruiting now
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
- Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) — Running, not enrolling
- Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy — Completed
- SHARE: Sharing Healthcare Wishes in Primary Care — Completed
- Nudging Effective and Equitable Delivery of Specialty Palliative Care — Enrolling by invitation
- Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy — Completed
- Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants — Completed
- Intensive Education Versus Usual Education of Patients for Improving Guideline Directed Medical Therapy (GDMT) Prescription in Heart Failure With Reduced Ejection Fraction — Status unconfirmed
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed